BRAIN Biotech AG (ETR:BNN)
Germany · Delayed Price · Currency is EUR 2.850
+0.020 (0.71%)
Aug 17, 2026, 9:17 AM CET
BRAIN Biotech AG Market Cap
BRAIN Biotech AG has a market cap or net worth of €61.83 million as of August 17, 2026. Its market cap has increased by 42.93% in one year.
Market Cap
61.83M
Enterprise Value
64.55M
Revenue
48.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.85
ChartMarket Cap Chart
Since February 9, 2016, BRAIN Biotech AG's market cap has decreased from 149.34M to 61.83M, a decrease of -58.60%. That is a compound annual growth rate of -8.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 61.83M | 12.30% |
| Dec 30, 2025 | 55.06M | -29.01% |
| Dec 30, 2024 | 77.56M | -3.01% |
| Dec 29, 2023 | 79.96M | -37.33% |
| Dec 30, 2022 | 127.59M | -37.20% |
| Dec 30, 2021 | 203.18M | 13.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Brenntag SE | 8.86B |
| Evonik Industries AG | 8.41B |
| Fuchs SE | 4.79B |
| Wacker Chemie AG | 4.70B |
| Verbio SE | 1.94B |
| AlzChem Group AG | 1.67B |
| LANXESS Aktiengesellschaft | 1.29B |
| Uzin Utz SE | 313.76M |